CCL5 and myeloid sarcoma: In addition, altered levels of CC chemokines and receptors have been identified in the serum and cerebrospinal fluid (CSF) of MS patients; some are elevated (including CCL5), whilst CCL2 is decreased in the CSF [22-26], possibly due to removal by CCR2-positive migrating cells as they cross the blood-brain barrier [27].